 Nicholas Behrendt
Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Prenatal | 10 | 2024 | 285 | 1.680 |
Why?
| | Fetofetal Transfusion | 5 | 2025 | 26 | 1.520 |
Why?
| | Pregnancy, Twin | 3 | 2022 | 19 | 1.030 |
Why?
| | Meningomyelocele | 5 | 2022 | 59 | 0.770 |
Why?
| | Laser Coagulation | 2 | 2025 | 68 | 0.710 |
Why?
| | Premature Birth | 4 | 2023 | 333 | 0.680 |
Why?
| | Cervix Uteri | 3 | 2022 | 48 | 0.670 |
Why?
| | Hydrocephalus | 2 | 2022 | 106 | 0.640 |
Why?
| | Pregnancy | 24 | 2025 | 6763 | 0.610 |
Why?
| | Fetal Development | 2 | 2021 | 296 | 0.580 |
Why?
| | Fetal Growth Retardation | 2 | 2025 | 565 | 0.510 |
Why?
| | Cervical Ripening | 2 | 2013 | 9 | 0.490 |
Why?
| | Lateral Ventricles | 1 | 2016 | 35 | 0.490 |
Why?
| | Pregnancy Complications | 4 | 2024 | 527 | 0.430 |
Why?
| | Fetoscopy | 3 | 2025 | 30 | 0.420 |
Why?
| | Placenta | 3 | 2016 | 750 | 0.410 |
Why?
| | Uterine Hemorrhage | 1 | 2013 | 37 | 0.400 |
Why?
| | Pregnancy Outcome | 4 | 2024 | 416 | 0.400 |
Why?
| | Fetus | 3 | 2023 | 806 | 0.390 |
Why?
| | Sex Determination Analysis | 1 | 2011 | 6 | 0.360 |
Why?
| | Gestational Age | 3 | 2022 | 910 | 0.340 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3566 | 0.330 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2023 | 201 | 0.330 |
Why?
| | Gastroschisis | 2 | 2020 | 29 | 0.320 |
Why?
| | Polycythemia | 2 | 2021 | 21 | 0.300 |
Why?
| | Fetal Therapies | 2 | 2019 | 42 | 0.290 |
Why?
| | Twins, Monozygotic | 2 | 2021 | 203 | 0.280 |
Why?
| | Comorbidity | 2 | 2024 | 1622 | 0.280 |
Why?
| | Body Mass Index | 2 | 2019 | 2389 | 0.280 |
Why?
| | Female | 26 | 2025 | 73304 | 0.230 |
Why?
| | Micrognathism | 1 | 2024 | 18 | 0.220 |
Why?
| | Bartter Syndrome | 1 | 2023 | 8 | 0.220 |
Why?
| | Polyhydramnios | 1 | 2023 | 17 | 0.220 |
Why?
| | Hernia, Umbilical | 1 | 2023 | 17 | 0.210 |
Why?
| | Abortion, Spontaneous | 1 | 2023 | 105 | 0.200 |
Why?
| | Urethral Obstruction | 1 | 2022 | 9 | 0.190 |
Why?
| | Urethral Diseases | 1 | 2022 | 19 | 0.190 |
Why?
| | Uterine Cervical Diseases | 1 | 2022 | 6 | 0.190 |
Why?
| | Amniotic Fluid | 1 | 2022 | 96 | 0.190 |
Why?
| | Urinary Tract | 1 | 2022 | 51 | 0.180 |
Why?
| | Pregnancy Reduction, Multifetal | 1 | 2021 | 5 | 0.180 |
Why?
| | Prenatal Care | 3 | 2022 | 294 | 0.170 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 242 | 0.170 |
Why?
| | Twins, Dizygotic | 1 | 2021 | 175 | 0.170 |
Why?
| | Fetal Diseases | 1 | 2022 | 173 | 0.170 |
Why?
| | Retrospective Studies | 11 | 2024 | 15657 | 0.170 |
Why?
| | Fetal Death | 2 | 2023 | 55 | 0.160 |
Why?
| | Delivery, Obstetric | 1 | 2021 | 144 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2022 | 162 | 0.160 |
Why?
| | Humans | 26 | 2025 | 137585 | 0.160 |
Why?
| | Anemia | 1 | 2021 | 170 | 0.160 |
Why?
| | Obstetric Surgical Procedures | 1 | 2019 | 6 | 0.160 |
Why?
| | Maternal Health | 1 | 2019 | 49 | 0.150 |
Why?
| | Tocolytic Agents | 1 | 2018 | 16 | 0.150 |
Why?
| | Indomethacin | 1 | 2018 | 81 | 0.150 |
Why?
| | Ductus Arteriosus | 1 | 2018 | 73 | 0.150 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2022 | 301 | 0.150 |
Why?
| | Maternal Exposure | 1 | 2020 | 190 | 0.140 |
Why?
| | Hysterotomy | 1 | 2017 | 9 | 0.140 |
Why?
| | Muscle Proteins | 2 | 2009 | 231 | 0.140 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 350 | 0.120 |
Why?
| | Risk Factors | 4 | 2025 | 10388 | 0.120 |
Why?
| | Pregnancy, Multiple | 1 | 2014 | 17 | 0.110 |
Why?
| | Prospective Studies | 4 | 2025 | 7604 | 0.110 |
Why?
| | Kidney | 1 | 2022 | 1468 | 0.110 |
Why?
| | Twins | 1 | 2014 | 243 | 0.100 |
Why?
| | Opioid-Related Disorders | 1 | 2020 | 515 | 0.100 |
Why?
| | Abnormalities, Multiple | 1 | 2014 | 189 | 0.100 |
Why?
| | Membrane Proteins | 2 | 2009 | 1164 | 0.100 |
Why?
| | Heart Defects, Congenital | 2 | 2024 | 842 | 0.100 |
Why?
| | Infant, Newborn | 5 | 2024 | 6079 | 0.090 |
Why?
| | Organ Size | 1 | 2013 | 477 | 0.090 |
Why?
| | Fetal Membranes, Premature Rupture | 1 | 2011 | 37 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1910 | 0.080 |
Why?
| | Pregnancy Trimester, First | 1 | 2011 | 140 | 0.080 |
Why?
| | Trophoblasts | 2 | 2009 | 199 | 0.080 |
Why?
| | Adult | 8 | 2025 | 37929 | 0.080 |
Why?
| | Predictive Value of Tests | 2 | 2011 | 2031 | 0.080 |
Why?
| | Young Adult | 5 | 2020 | 13209 | 0.070 |
Why?
| | Pre-Eclampsia | 1 | 2009 | 190 | 0.070 |
Why?
| | Obesity | 1 | 2019 | 2992 | 0.060 |
Why?
| | Registries | 2 | 2025 | 2035 | 0.060 |
Why?
| | Anatomic Landmarks | 1 | 2024 | 29 | 0.060 |
Why?
| | Jaw | 1 | 2024 | 26 | 0.060 |
Why?
| | Infant | 3 | 2023 | 9465 | 0.060 |
Why?
| | Lung Volume Measurements | 1 | 2023 | 46 | 0.050 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2024 | 121 | 0.050 |
Why?
| | Prenatal Diagnosis | 1 | 2024 | 201 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 324 | 0.050 |
Why?
| | Cerclage, Cervical | 1 | 2022 | 6 | 0.050 |
Why?
| | Antigens, Neoplasm | 1 | 2023 | 319 | 0.040 |
Why?
| | Bupivacaine | 1 | 2020 | 32 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2023 | 430 | 0.040 |
Why?
| | Anesthetics, Local | 1 | 2020 | 80 | 0.040 |
Why?
| | Maternal Age | 1 | 2020 | 129 | 0.040 |
Why?
| | Lung | 2 | 2023 | 4060 | 0.040 |
Why?
| | Dysferlin | 2 | 2009 | 3 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4565 | 0.040 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2019 | 36 | 0.040 |
Why?
| | Perinatal Death | 1 | 2019 | 25 | 0.040 |
Why?
| | Constriction | 1 | 2018 | 47 | 0.040 |
Why?
| | Tissue Distribution | 2 | 2009 | 332 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.040 |
Why?
| | Pain, Postoperative | 1 | 2020 | 265 | 0.040 |
Why?
| | Calcium-Binding Proteins | 2 | 2009 | 218 | 0.030 |
Why?
| | Case-Control Studies | 2 | 2020 | 3556 | 0.030 |
Why?
| | Survival Rate | 1 | 2022 | 1972 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 2019 | 202 | 0.030 |
Why?
| | Time Factors | 2 | 2019 | 6828 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2057 | 0.030 |
Why?
| | Health Status | 1 | 2019 | 792 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2020 | 1000 | 0.020 |
Why?
| | Term Birth | 1 | 2011 | 23 | 0.020 |
Why?
| | Uterine Contraction | 1 | 2011 | 17 | 0.020 |
Why?
| | Pregnancy Trimester, Second | 1 | 2011 | 80 | 0.020 |
Why?
| | Male | 2 | 2024 | 67762 | 0.020 |
Why?
| | Risk Assessment | 1 | 2019 | 3457 | 0.020 |
Why?
| | Reference Values | 1 | 2011 | 816 | 0.020 |
Why?
| | HL-60 Cells | 1 | 2009 | 34 | 0.020 |
Why?
| | Cell Fusion | 1 | 2009 | 51 | 0.020 |
Why?
| | Colforsin | 1 | 2009 | 53 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2011 | 275 | 0.020 |
Why?
| | Cell-Derived Microparticles | 1 | 2009 | 71 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1316 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5131 | 0.020 |
Why?
| | Adolescent | 2 | 2022 | 21513 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2019 | 2654 | 0.020 |
Why?
| | Down-Regulation | 1 | 2009 | 657 | 0.020 |
Why?
| | Cell Membrane | 1 | 2009 | 738 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10811 | 0.010 |
Why?
| | Phenotype | 1 | 2011 | 3196 | 0.010 |
Why?
| | Models, Biological | 1 | 2009 | 1783 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2009 | 2833 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2009 | 4193 | 0.010 |
Why?
| | Cohort Studies | 1 | 2011 | 5742 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2009 | 2607 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2009 | 5472 | 0.010 |
Why?
| | Middle Aged | 1 | 2009 | 33479 | 0.000 |
Why?
|
|
Behrendt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|